Clinical Trial Update: Xihuang Capsules Prevention of Recurrence in Patients With Hepatocellular Carcinoma After Hepatectomy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Xihuang Capsules for preventing recurrence of hepatocellular carcinoma after hepatectomy; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Xihuang Capsules

Snippet

Sponsor: Shuqun Cheng | Conditions: Hepatocellular Carcinoma | Phase 4 | Status: UNKNOWN